Measurable residual disease in chronic lymphocytic leukemia: expert re-view and consensus recommendations.

Wierda, WG; Rawstron, A; Cymbalista, F; Badoux, X; Rossi, D; Brown, JR; Egle, A; Abello, V; Ceballos, EC; Herishanu, Y; Mulligan, SP; Niemann, CU; Diong, CP; Soysal, T; Suzuki, R; Tran, HTT; Wu, SJ; Owen, C; Stilgenbauer, S; Ghia, P; Hillmen, P.
Leukemia. 2021 Jun 24. doi: 10.1038/s41375-021-01241-1. Online ahead of print.